Prolensa Effective for the Treatment of Pain, Inflammation After Cataract Surgery

In the second of two phase 3 studies of bromfenac ophthalmic solution (Prolensa; Ista Pharmaceuticals, Inc.) for the treatment of pain and inflammation after cataract surgery, the agent met the study’s primary and secondary efficacy endpoints, according to a company news release. Prolensa, which is a low concentratio...

Full Story →